These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27406319)

  • 21. The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial.
    Ibrahim O; Kakar R; Bolotin D; Nodzenski M; Disphanurat W; Pace N; Becker L; West DP; Poon E; Veledar E; Alam M
    J Am Acad Dermatol; 2013 Jul; 69(1):88-95. PubMed ID: 23591103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
    Maillard H; Briand N; Bara C; Celerier P
    Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
    Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
    Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Axillary hyperhidrosis, botulinium A toxin treatment: Review].
    Clerico C; Fernandez J; Camuzard O; Chignon-Sicard B; Ihrai T
    Ann Chir Plast Esthet; 2016 Feb; 61(1):60-4. PubMed ID: 25555435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
    Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T
    Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Durability of botulinum toxin treatment for axillary hyperhidrosis.
    Moffat CE; Hayes WG; Nyamekye IK
    Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):188-91. PubMed ID: 19395290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis.
    Flanagan KH; King R; Glaser DA
    J Drugs Dermatol; 2008 Mar; 7(3):221-7. PubMed ID: 18380203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type B: a new therapy for axillary hyperhidrosis.
    Nelson L; Bachoo P; Holmes J
    Br J Plast Surg; 2005 Mar; 58(2):228-32. PubMed ID: 15710119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of compensatory gustatory hyperhidrosis with topical glycopyrrolate.
    Kim WO; Kil HK; Yoon DM; Cho MJ
    Yonsei Med J; 2003 Aug; 44(4):579-82. PubMed ID: 12950111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin--a possible new treatment for axillary hyperhidrosis.
    Bushara KO; Park DM; Jones JC; Schutta HS
    Clin Exp Dermatol; 1996 Jul; 21(4):276-8. PubMed ID: 8959898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of isolated axillary hyperhidrosis successfully treated topically with 1% glycopyrronium cream.
    Sega-Hall GM; Smith P; Haworth AE
    Clin Exp Dermatol; 2006 Nov; 31(6):825. PubMed ID: 17040271
    [No Abstract]   [Full Text] [Related]  

  • 35. Topical local anaesthetic (tetracaine) reduces pain from botulinum toxin injections for axillary hyperhidrosis.
    O'Riordan JM; Fitzgerald E; Gowing C; O'Grady H; Feeley TM; Tierney S
    Br J Surg; 2006 Jun; 93(6):713-4. PubMed ID: 16671065
    [No Abstract]   [Full Text] [Related]  

  • 36. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Successful treatment of diabetic gustatory hyperhidrosis with topical glycopyrrolate].
    Lund NS; Maxel T; Rungby J
    Ugeskr Laeger; 2011 Sep; 173(36):2200-1. PubMed ID: 21893005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Our experience of glycopyrrolate 2% cream for axillary hyperhidrosis.
    Hale DR; MacKenzie AI; Kavanagh GM
    Br J Dermatol; 2014 Jun; 170(6):1373. PubMed ID: 24484220
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment options for hyperhidrosis.
    Walling HW; Swick BL
    Am J Clin Dermatol; 2011 Oct; 12(5):285-95. PubMed ID: 21714579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double-blinded, placebo-controlled, split-face study.
    Hyun MY; Son IP; Lee Y; Choi HG; Park KY; Li K; Kim BJ; Seo SJ; Kim MN; Hong CK
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):278-282. PubMed ID: 24909188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.